Star Biosciences is a subsidiary of Star Health Network, Inc.
Star Biosciences is focused on oncology and serves Clinician, patients, academic researchers and drug developers with comprehensive repertoire of oncology testing - from IHC to molecular diagnostics to next generations sequencing.
Star Biosciences supports patients in India- SE-Asia- Africa, which accounts for more than 50% of the world’s cancer population. Through clinical assays, the company identifies the molecular alterations in a patient's cancer and matches them with relevant targeted therapies and clinical trials.
Star Biosciences also supports academic researchers and drug developers with Bio-Marker Discovery, Clinical Trials patient identification and operations and Real world Evidence (RWE) data, all services intended to help advance the science of molecular medicine in cancer.
Company Details
- Employees
- 1
- Founded
- 2017
- Address
- New York, Ny 10021, Us
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.starbiosciences.com
- HQ
- New York, NY
Star Biosciences Questions
Star Biosciences's website is http://www.starbiosciences.com
Star Biosciences's LinkedIn profile is https://www.linkedin.com/company/star-biosciences
Star Biosciences has
1 employees.
View email and phone details for 1
employees at Star Biosciences.
Star Biosciences's industry is
Biotechnology Research
Star Biosciences's top competitors are
Medexec,
Pharmapulse Consultant Group Llc,
Equiclin,
Evidence 360,
Evalus Ai,
Clineepi Partners,
The Litaker Group (Rwe, Population Health),
Polaris Strategic Partners, Inc.,
Lucyna,
Datathreads.
Star Biosciences's categories are Biotechnology Research
Star Biosciences's founding year is 2017
